We further observed notable increases in expression levels of PCNA, β-catenin, and MDM2 widely recognized as cell proliferation markers associated with colon cancer in the AOM/DSS-treated mice (Supplementary Fig. 4c). Here, MDM2 is linked to malignant colon neoplasm.